DPHARMA | DUOPHARMA BIOTECH BHD

7
1.29 (0.0%)

T-O (am): 0.000 (08:59:00)
Last updated: 11:15

Fundamental
Technical
Total Score
DPHARMA | DUOPHARMA BIOTECH BHD

DPHARMA Support & Resistance

ATR Trailing Stop: 1.27

Support
Last Price
Resistance
Price 1.24 1.25 1.26 1.28 1.29 1.29 1.29 1.3 1.31 1.32 1.33
Volume (M) 94.1 99.2 63.2 34.9 68.2 68.2 72.6 44.0 29.4 29.0

Gann Support: 1.27/1.21 | Resistance: 1.33/1.39

*Highlighted column shows significant volume at the support or resistance area.

DPHARMA Technical Trend

DPHARMA Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

DPHARMA Pivot Point

S2
S1
P
R1
R2
Daily 1.28 1.29 1.29 1.3 1.3
Weekly 1.24 1.27 1.3 1.33 1.36

DPHARMA Summary


Market Cap: 1240 M.

Market Cap Class: Middlers

Number of Shares: 961 M.

Adjusted Float: 47.0%.

Stock highly correlated with

LHI (49%)

TAKAFUL (49%)

ORIENT (48%)

SCIENTX (48%)

Duopharma Biotech Berhad, formerly known as CCM Duopharma Biotech Berhad. Duopharma core competencies in the pharmaceutical industry include manufacturing, research and development, and commercialization and marketing of over 300 generic drugs, including Omesec and Prelica, as well as Consumer Healthcare (CHC) products such as CHAMPS, FLAVETTES, PROVITON, and Uphamol, which are well-known and accepted by consumers in Malaysia, the region, and around the world. With technological and commercialization agreements with trustworthy and powerful international partners, the Company has also ventured into the biosimilars space.Their headquarters is located in Kuala Lumpur, Malaysia.

Sectors: Consumer Products, Healthcare, Pharmaceuticals, Vaccine

Code: 7148

Website: http://duopharmabiotech.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

DPHARMA Top Shareholdings

Updated on 31-Mar-2023

Shareholder % Value (M)
Permodalan Nasional Berhad 44.0% 546.05
Employees Provident Fund Board 10.44% 129.6
Amanah Saham Bumiputera 4.43% 54.92
Amanah Saham Malaysia 2.31% 28.66
Tabung Haji 1.92% 23.83
Billion Victory Sdn Bhd 1.58% 19.63
National Trust Fund 1.33% 16.52
Public Islamic Treasures Growth Fund 1.06% 13.14
Manulife Investment Shariah Progress Fund 0.91% 11.29
Prulink Equity Fund 0.74% 9.2
Eastspring Investments Small-Cap Fund 0.56% 6.92
Participating Fund 0.55% 6.84
Prulink Strategic Fund 0.49% 6.11
Manulife Investment Progress Fund 0.38% 4.72
Manulife Investment Al Fauzan 0.37% 4.59
Principal Dali Equity Growth Fund 0.34% 4.19
Asean Growth Fund 0.33% 4.03
Syarikat Takaful Malaysia Keluarga Berhad 0.32% 4.02
Affin Hwang Wholesale Equity Fund 0.28% 3.46
Hong Leong Assurance Berhad 0.27% 3.39
Ooi Keng Tan 0.27% 3.36
Kenanga Shariah Growth Opportunities Fund 0.25% 3.13
Gibraltar BSN Aggressive Fund 0.19% 2.33
Hong Leong Msig Takaful Berhad 0.18% 2.3
Frequently Asked Questions
Duopharma Biotech Berhad, formerly known as CCM Duopharma Biotech Berhad. Duopharma core competencies in the pharmaceutical industry include manufacturing, research and development, and commercialization and marketing of over 300 generic drugs, including Omesec and Prelica, as well as Consumer Healthcare (CHC) products such as CHAMPS, FLAVETTES, PROVITON, and Uphamol, which are well-known and accepted by consumers in Malaysia, the region, and around the world. With technological and commercialization agreements with trustworthy and powerful international partners, the Company has also ventured into the biosimilars space.Their headquarters is located in Kuala Lumpur, Malaysia. The company is listed on Bursa Malaysia and operates in the Consumer Products, Healthcare, Pharmaceuticals and Vaccine sectors.
Yes, DUOPHARMA BIOTECH BHD is listed as Shariah-compliant.
The latest share price of DUOPHARMA BIOTECH BHD is RM 1.29 updated on 23 January 2026 11:15.
As of now, DUOPHARMA BIOTECH BHD has a market capitalization of 1240M based on the latest financial data.
iSaham's technical analysis indicates that DUOPHARMA BIOTECH BHD's support level is at RM 1.25 and its resistance level is at RM 1.3, based on moving averages and price patterns.
The 52-week high for DUOPHARMA BIOTECH BHD is RM 1.34
DUOPHARMA BIOTECH BHD's share price has increased by 4.03% year-to-date, influenced by market trends and company performance.
DUOPHARMA BIOTECH BHD declared a dividend of 3.5 sen for the year 2025-11-13. View more details on DUOPHARMA BIOTECH BHD's Historical Dividends page.
The main shareholders of DUOPHARMA BIOTECH BHD include Permodalan Nasional Berhad, Employees Provident Fund Board and Amanah Saham Bumiputera. View more on DUOPHARMA BIOTECH BHD Top Shareholders page.
You can buy DUOPHARMA BIOTECH BHD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.